Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Alethiomics Logo
Alethiomics Growth Score
58
CB Rank
91966
Heat Score
11
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
Founded
obfuscation
PrivateSeed Headington, Oxfordshire, United Kingdom1-10 www.alethiomics.com
Biotechnology
Therapeutics
Overview

Alethiomics
Total Funding
obfuscation
Growth Score
58
Heat Score
11

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score58
-3 pts
in past quarter
Heat Score 11
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Alethiomics

CB Rank
91966
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
Founded
obfuscation
PrivateSeed Headington, Oxfordshire, United Kingdom1-10 www.alethiomics.com
Biotechnology
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Alethiomics Ltd
Operating Status Active
Company Type For Profit
Founders  Adam Mead, Bethan Psaila
About the Company
Alethiomics is a pre-clinical biotech company harnessing the power of single-cell multi-omic technology to discover and develop life-changing treatments for patients with blood cancer.
Contact Email hello@alethiomics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

TARGET-seq
A platform that uses multi-omic information from single cells to understand disease and identify targets in cancer stem cells with high resolution and sensitivity.
Novel Therapies
Therapeutics developed based on discoveries from the TARGET-seq platform, aimed at targeting MPN stem cells and potentially other cancers.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed
obfuscation
Seed Round - Alethiomics Logo
Seed Round - Alethiomics
1
obfuscation
Oxford Science EnterprisesSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 3

Employee Profiles

News

News and Press

News•Sep 4, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 15, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

11Alethiomics is actively using 11 technologies for its website, according to BuiltWith. These include Common Crawl, DNSSEC, and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Alethiomics's headquarters? Alethiomics is located in Headington, Oxfordshire, United Kingdom.Who invested in Alethiomics? Alethiomics is funded by Oxford Science Enterprises.When was the last funding round for Alethiomics? Alethiomics closed its last funding round on
obfuscation
from a Seed round.Who are Alethiomics's competitors? Alternatives and possible competitors to Alethiomics may include Parse Biosciences, Mission Bio, and  BD.How much funding has Alethiomics raised to date? Alethiomics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(c47a730 1)
|